Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Pfenex, US Government Extends Anthrax Vaccine Pact

October 08, 2013

Pfenex modifies its contract with US government for Anthrax vaccine.

3M Drug Delivery to Manufacture Transdermal Patch in Europe

October 08, 2013

3M Drug Delivery will manufacture transdermal patch for ProStrakan.

Advanced Biosciences Laboratories, PATH Partner in Vaccine Production

October 04, 2013

Advanced Biosciences Laboratories will support the development and production of a novel Shigella vaccine candidate for PATH.

Elucidating Biosimilars Characterization

October 02, 2013

Industry experts discuss the importance of characterization studies during biosimilars development and related analytical methods.

Tablet-Sticking Solutions

October 02, 2013

Analytical methods are being used to troubleshoot tablet-sticking problems and to develop screening methods and predictive models to more quickly find solutions.

Softgels

October 01, 2013

An industry leader since 1933, Catalent develops and manufactures over 80% of the world's Rx softgel products with 200+ products on the market in 80+ countries.

Boehringer Ingelheim Voluntarily Recalls Certain Lots of Spiriva Handihaler Capsules

September 25, 2013

Boehringer Ingelheim initiates a recall due to the potential for extrinsic foreign particles in the API used to manufacture Spiriva Handihaler (tiotropium bromide inhalation powder) capsules.

Pfizer Applies Integrated Technology for Cell-Line Development of Proprietary Antibodies

September 25, 2013

Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.

First biosimilar mAb approved in Europe

September 13, 2013

Hospira's Inflectra (infliximab), which is a biosimilar to the reference biologic product, Remicade, has been approved by the EC for the treatment of inflammatory conditions.

Mechanical Control with Foam Granulation Well-Suited for Pharmaceutical Manufacturing

September 11, 2013

Foam granulation is much easier to control under mechanical dispersion conditions, which is where most industrial processes operate.